🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects

RecruitingPhase 4Ages 16 Years - 70 YearsAllAl-Shifa Trust Eye Hospital
NCT07561398 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

After an initial period of standard treatment, they received further care aimed at helping the surface of the eye heal. Clear instructions were given on how to use and store the treatment properly. Patients were then monitored regularly over several months, with doctors checking their healing progress during follow-up visits. The study continued for a total of 24 weeks to observe how well and how quickly the eye surface recovered.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Corneal epithelial defects for more than 2 weeks no improvement using standard treatment Exclusion Criteria: * • Systemic conditions e.g. uncontrolled Diabetes, autoimmune disorders * Recent eye surgery within last 3 months * Hereditary corneal dystrophies * Active eye infections
💊

What it tests

  • Topical insulin eye drops
  • Amniotic Membrane Graft
📍

Where

1 site
Al Shifa Eye Trust Hospital
Rawalpindi, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy